Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Angrist

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Psychopharmacology|January 1, 1996
Amphetamine and negative symptoms of schizophreniaM Sanfilipo, A Wolkin, B Angrist, et al.
Synapse (New York, N.Y.)|November 1, 1991
Effects of endogenous dopamine on measures of [18F]N-methylspiroperidol binding in the basal ganglia: comparison of simulations and experimental results from PET studies in baboonsJ Logan, S L Dewey, A P Wolf, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 2000
Diminished acoustic startle in chronic cocaine usersT R Efferen, E J Duncan, S Szilagyi, et al.
The American Journal of Psychiatry|March 1, 1996
Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptomsA Wolkin, M Sanfilipo, E Duncan, et al.
Synapse (New York, N.Y.)|April 1, 1994
Imaging endogenous dopamine competition with [11C]raclopride in the human brainN D Volkow, G J Wang, J S Fowler, et al.
The American Journal of Psychiatry|January 19, 1999
Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addictionN D Volkow, G J Wang, J S Fowler, et al.
Psychopharmacology|January 1, 1996
Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effectsN D Volkow, G J Wang, S J Gatley, et al.
Biological Psychiatry|September 1, 1994
Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatologyA Wolkin, M Sanfilipo, B Angrist, et al.
Molecular Psychiatry|December 1, 1999
Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitizationK Yui, K Goto, S Ikemoto, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 30, 2001
Clinical and sensorimotor gating effects of ketamine in normalsE J Duncan, S H Madonick, A Parwani, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Psychopharmacology|January 1, 1996
Amphetamine and negative symptoms of schizophreniaM Sanfilipo, A Wolkin, B Angrist, et al.
Synapse (New York, N.Y.)|November 1, 1991
Effects of endogenous dopamine on measures of [18F]N-methylspiroperidol binding in the basal ganglia: comparison of simulations and experimental results from PET studies in baboonsJ Logan, S L Dewey, A P Wolf, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 2000
Diminished acoustic startle in chronic cocaine usersT R Efferen, E J Duncan, S Szilagyi, et al.
The American Journal of Psychiatry|March 1, 1996
Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptomsA Wolkin, M Sanfilipo, E Duncan, et al.
Synapse (New York, N.Y.)|April 1, 1994
Imaging endogenous dopamine competition with [11C]raclopride in the human brainN D Volkow, G J Wang, J S Fowler, et al.
The American Journal of Psychiatry|January 19, 1999
Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addictionN D Volkow, G J Wang, J S Fowler, et al.
Psychopharmacology|January 1, 1996
Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effectsN D Volkow, G J Wang, S J Gatley, et al.
Biological Psychiatry|September 1, 1994
Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatologyA Wolkin, M Sanfilipo, B Angrist, et al.
Molecular Psychiatry|December 1, 1999
Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitizationK Yui, K Goto, S Ikemoto, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 30, 2001
Clinical and sensorimotor gating effects of ketamine in normalsE J Duncan, S H Madonick, A Parwani, et al.
Pageof 10